Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKesson
Express Scripts
Johnson and Johnson
Baxter

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Claims for Patent: 6,581,775

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,581,775
Title: Method of external genital cleansing and prophylactic kit
Abstract:A method of external genital cleansing and prophylactic kit are disclosed. The kit includes wipes having topical microbicides, personal lubricants, sterile water or sterile water-based solutions disposed on or impregnated therein. The wipes are packaged in conjunction with a condom and when used in accordance with the teaching of this invention work to inhibit transmission of STDs particularly including HIV. Wipes provided in the kit may be used to cleanse the external portions of the genitals before application of the provided condom. After removal of the condom, one or more wipes are to be used to cleanse the external portions of the genitals.
Inventor(s): Hagopian; Garo (Montebello, CA)
Assignee:
Application Number:09/927,944
Patent Claims:1. A prophylactic kit for use in connection with sexual intercourse and related intimate contacts between partners, said prophylactic kit comprises: a sealed enclosure, and therein: at least one condom; at least one first cleansing wipe container; said at least one first cleansing wipe container enclosing at least one first cleansing wipe; said at least one first cleansing wipe containing a first wipe solution comprised of a personal lubricant, nonirritating to mucosal tissues; and at least one second cleansing wipe container; said at least one second cleansing wipe container enclosing at least one second cleansing wipe; said at least one second cleansing wipe containing a second wipe solution comprised of nonoxynol-9 and glycerol.

2. The prophylactic kit as claimed in claim 1 further comprising at least one third cleansing wipe container; said at least one third cleansing wipe container enclosing at least one third cleansing wipe; said at least one third cleansing wipe containing a third wipe solution comprised of a nonirritating, sterile water-based solution.

3. The prophylactic kit as claimed in claim 1 further comprising at least one third cleansing wipe container; said at least one third cleansing wipe container enclosing at least one third cleansing wipe; said at least one third cleansing wipe containing a third wipe solution comprised of sterile water.

4. A prophylactic kit for use in connection with sexual intercourse and related intimate contacts between partners, said prophylactic kit comprises: a sealed enclosure, and therein: at least one condom; at least one first cleansing wipe container; said at least one first cleansing wipe container enclosing at least one first cleansing wipe; said at least one first cleansing wipe containing a first wipe solution comprised of a personal lubricant, nonirritating to mucosal tissues; and at least one second cleansing wipe container; said at least one second cleansing wipe container enclosing at least one second cleansing wipe; said at least one second cleansing wipe containing a second wipe solution comprised of nonoxynol-9.

5. The prophylactic kit as claimed in claim 4 further comprising at least one third cleansing wipe container; said at least one third cleansing wipe container enclosing at least one third cleansing wipe; said at least one third cleansing wipe containing a third wipe solution comprised of a nonirritating, sterile water-based solution.

6. The prophylactic kit as claimed in claim 4 further comprising at least one third cleansing wipe container; said at least one third cleansing wipe container enclosing at least one third cleansing wipe; said at least one third cleansing wipe containing a third wipe solution comprised of sterile water.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
McKinsey
Johnson and Johnson
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.